AFP and hepatocellular carcinoma: In addition to certain biomarkers, clinicopathological variables are easily accessible and have been widely applied to predict postoperative recurrence and clinical outcomes in HCC patients, including serum AFP level, tumor size, tumor number and the presence of MVI [4, 37].